よむ、つかう、まなぶ。
03資料1-1森野委員提出資料（高齢者に対するインフルエンザワクチンファクトシート） (42 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64997.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第32回 10／22）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
influenza vaccine is associated with cost savings and better outcomes compared to standard-dose
inactivated influenza vaccine in Canadian seniors. Hum Vaccin Immunother 2016; 12(12): 3036-42.
87.
Raviotta JM, Smith KJ, DePasse J, et al. Cost-Effectiveness and Public Health Effect of
Influenza Vaccine Strategies for U.S. Elderly Adults. J Am Geriatr Soc 2016; 64(10): 2126-31.
88.
Chit A, Becker DL, DiazGranados CA, Maschio M, Yau E, Drummond M. Cost-effectiveness of
high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an
economic evaluation of data from a randomised controlled trial. Lancet Infect Dis 2015; 15(12): 1459-66.
89.
Chit A, Roiz J, Briquet B, Greenberg DP. Expected cost effectiveness of high-dose trivalent
influenza vaccine in US seniors. Vaccine 2015; 33(5): 734-41.
90.
U.S. Centers for Disease Control and Prevention. Influenza (Flu), Recombinant Influenza (Flu)
Vaccine. 2024/09/09 2024. https://www.cdc.gov/flu/vaccine-types/flublokvaccine.html?CDC_AAref_Val=https://www.cdc.gov/flu/prevent/qa_flublok-vaccine.htm (accessed
2025/10/06
91.
Grohskopf LA, Ferdinands JM, Blanton LH, Broder KR, Loehr J. Prevention and Control of
Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization
Practices - United States, 2024-25 Influenza Season. MMWR Recomm Rep 2024; 73(5): 1-25.
92.
Zhao T, Cai Y, Jiang Y, et al. Vaccine adjuvants: mechanisms and platforms. Signal Transduct
Target Ther 2023; 8(1): 283.
93.
U.S. Centers for Disease Control and Prevention. Influenza (Flu), Adjuvanted Flu Vaccine.
2022/08/25 2022. https://www.cdc.gov/flu/vaccinetypes/adjuvant.html?CDC_AAref_Val=https://www.cdc.gov/flu/prevent/adjuvant.htm (accessed 2025/10/06
94.
Sinilaite A, Gemmill I, Harrison R. Summary of the NACI Supplemental Statement on
Mammalian Cell Culture-Based Influenza Vaccines. Can Commun Dis Rep 2020; 46(10): 324-32.
95.
Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines:
recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm
Rep 2010; 59(Rr-8): 1-62.
96.
Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and Control of Seasonal Influenza
with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States,
2022-23 Influenza Season. MMWR Recomm Rep 2022; 71(1): 1-28.
97.
Department of Health & Social Care. JCVI statement on influenza vaccines for 2025 to 2026.
2024/12/03 2024. https://www.gov.uk/government/publications/flu-vaccines-2025-to-2026-jcvi-advice/jcvistatement-on-influenza-vaccines-for-2025-to-2026 (accessed 2025/10/06).
98.
Public Health Agency of Canada. Canadian Immunization Guide Chapter on Influenza and
Statement on Seasonal Influenza Vaccine for 2016-2017. 2025/06/13 2016.
https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-onimmunization-naci/canadian-immunization-guide-chapter-on-influenza-statement-on-seasonal-influenzavaccine-2016-2017-advisory-committee-statement.html (accessed 2025/10/06).
99.
Public Health Agency of Canada. Supplemental guidance on influenza vaccination in adults 65
42
inactivated influenza vaccine in Canadian seniors. Hum Vaccin Immunother 2016; 12(12): 3036-42.
87.
Raviotta JM, Smith KJ, DePasse J, et al. Cost-Effectiveness and Public Health Effect of
Influenza Vaccine Strategies for U.S. Elderly Adults. J Am Geriatr Soc 2016; 64(10): 2126-31.
88.
Chit A, Becker DL, DiazGranados CA, Maschio M, Yau E, Drummond M. Cost-effectiveness of
high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an
economic evaluation of data from a randomised controlled trial. Lancet Infect Dis 2015; 15(12): 1459-66.
89.
Chit A, Roiz J, Briquet B, Greenberg DP. Expected cost effectiveness of high-dose trivalent
influenza vaccine in US seniors. Vaccine 2015; 33(5): 734-41.
90.
U.S. Centers for Disease Control and Prevention. Influenza (Flu), Recombinant Influenza (Flu)
Vaccine. 2024/09/09 2024. https://www.cdc.gov/flu/vaccine-types/flublokvaccine.html?CDC_AAref_Val=https://www.cdc.gov/flu/prevent/qa_flublok-vaccine.htm (accessed
2025/10/06
91.
Grohskopf LA, Ferdinands JM, Blanton LH, Broder KR, Loehr J. Prevention and Control of
Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization
Practices - United States, 2024-25 Influenza Season. MMWR Recomm Rep 2024; 73(5): 1-25.
92.
Zhao T, Cai Y, Jiang Y, et al. Vaccine adjuvants: mechanisms and platforms. Signal Transduct
Target Ther 2023; 8(1): 283.
93.
U.S. Centers for Disease Control and Prevention. Influenza (Flu), Adjuvanted Flu Vaccine.
2022/08/25 2022. https://www.cdc.gov/flu/vaccinetypes/adjuvant.html?CDC_AAref_Val=https://www.cdc.gov/flu/prevent/adjuvant.htm (accessed 2025/10/06
94.
Sinilaite A, Gemmill I, Harrison R. Summary of the NACI Supplemental Statement on
Mammalian Cell Culture-Based Influenza Vaccines. Can Commun Dis Rep 2020; 46(10): 324-32.
95.
Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines:
recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm
Rep 2010; 59(Rr-8): 1-62.
96.
Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and Control of Seasonal Influenza
with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States,
2022-23 Influenza Season. MMWR Recomm Rep 2022; 71(1): 1-28.
97.
Department of Health & Social Care. JCVI statement on influenza vaccines for 2025 to 2026.
2024/12/03 2024. https://www.gov.uk/government/publications/flu-vaccines-2025-to-2026-jcvi-advice/jcvistatement-on-influenza-vaccines-for-2025-to-2026 (accessed 2025/10/06).
98.
Public Health Agency of Canada. Canadian Immunization Guide Chapter on Influenza and
Statement on Seasonal Influenza Vaccine for 2016-2017. 2025/06/13 2016.
https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-onimmunization-naci/canadian-immunization-guide-chapter-on-influenza-statement-on-seasonal-influenzavaccine-2016-2017-advisory-committee-statement.html (accessed 2025/10/06).
99.
Public Health Agency of Canada. Supplemental guidance on influenza vaccination in adults 65
42